Patients are returning to doctors in record numbers for Botox, a corporate executive announced at a health care summit.
The CEO for Botox maker Allergan, Inc., announced at the Reuters Health Summit last week that, "Happily, for all of the facial aesthetics and even breast aesthetics markets, we are now at a place that we are beyond the peak pre-recession."
He told Reuters demand for cosmetic procedures hit bottom in the spring of 2009 in the wake of the global financial crisis. But sales of Allergan's dermal fillers are 20% above where they peaked before the recession, fueled not just by the super-rich, but by consumers with an annual household income of at least $50,000.
"It's correlated with people's confidence about the future, maybe how much money they have got on their credit card at the time," the CEO added.
The news comes at a time when many uninsured patients can't afford a hospital visit, and when Medicare is becoming increasingly insolvent. We may die young from all this, as they say, but we'll have good looking corpses.